MAPT and Alzheimer disease: One study demonstrated a significant upregulation of S1P and S1PR1 expression in senescent 5xFAD mice (an AD model) compared to wild-type mice, along with enhanced activation of the Akt/mTOR/Tau signaling pathway, which is downstream of S1PR1 (Jung et al., 2023).